Getinge

Report Publication Announcement • May 25, 2014

PRESS RELEASE 25 May 2014

Getinge postpones 27 May Capital Markets Day and reschedules for a later date to be announced

Getinge announced today that it is rescheduling its Capital Markets Day for a later date to be announced. This decision was made based on very recent communications with the U.S. Food & Drug Administration (FDA), which are the subject of active discussions.

Getinge Group will hold its Capital Markets Day when it has more to report about these discussions, their potential financial impact on the company, and the latest progress being made in strengthening Medical Systems' quality management systems.

Getinge apologizes to those who had made plans to attend the Capital Markets Day and are inconvenienced by the rescheduling.

As announced earlier, the Medical Systems business area has been in a dialogue with the FDA to ensure that efforts made to strengthen its quality management system fully meet the FDA's requirements based on a series of inspections that took place last year. The enhancements at Medical Systems are well under way and are expected to be completed during the second half of 2015, and, as previously disclosed, costs for these efforts are expected to amount to approximately SEK 800 million and were charged to the first quarter results of 2014.

This announcement will be followed by a conference call at 10.00 AM CET tomorrow, hosted by Johan Malmquist, CEO Getinge Group and Ulf Grunander, CFO Getinge Group.

Conference Call

To participate, please call: Sweden: +46 (0)8 5853 6965 UK: +44 (0)20 3427 1914 US: +1 646 254 3361 Passcode: 6903282

Agenda 09.45 Call the conference number 10.00 Introduction 10.10 Q&A 11.00 End of conference

A recorded version of the conference will be accessible for five working days at the following number: Sweden: +46 (0)8 5051 3897

UK: +44 (0)20 3427 0598 US: +1 347 366 95 65 Passcode: 6903282

The Getinge Group is a global leading medical technology company that operates in the areas of surgery, intensive care, infection control, care ergonomics and wound care. The Group is divided into three business areas: Medical Systems, Extended Care and Infection Control and operates under the brands ArjoHuntleigh, Getinge and Maquet.